Author | Saad Z. Usmani, MD | OncLive

Author | Saad Z. Usmani, MD


Dr. Usmani on Current Challenges in High-Risk Multiple Myeloma

June 25, 2020


Saad Z. Usmani, MD, FACP, discusses current challenges in patients with high-risk multiple myeloma.

Dr. Usmani on Activity of Teclistamab in Relapsed/Refractory Multiple Myeloma

June 01, 2020


Saad Usmani, MD, discusses research with teclistamab (JNJ-64007957) in relapsed/refractory multiple myeloma presented at the 2020 ASCO Virtual Scientific Program.

Dr. Usmani Discusses Immunotherapy in Hematologic Malignancies

June 12, 2018


Saad Z. Usmani, MD, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Carolinas HealthCare System, discusses immunotherapy in hematologic malignancies.

Dr. Usmani on PD-1/PD-L1 Inhibitors in Hematologic Malignancies

April 30, 2018


Saad Z. Usmani, MD, clinical professor of medicine, UNC-Chapel Hill School of Medicine, chief, Plasma Cell Disorders Program, director, clinical research in hematologic malignancies, Levine Cancer Institute, discusses the evolution of PD-1/PD-L1 inhibitors in the treatment of patients with hematologic malignancies.